Home
About
Back
About Us
Management Team
Board of Directors
Clinical Advisors
Factsheet
Pipeline
Back
Pipeline
VDA-1102 Ointment
VDA-1102 IV
VDA-1275
Therapeutic Areas
Back
Oncology
Back
Solid Tumors
Cutaneous T-Cell Lymphoma (CTCL)
Dermatology
Back
Skin Cancer
Cutaneous Squamous Cell Carcinoma (cSCC)
Actinic Keratosis
Clinical Trials
Back
VDA-1102 Ointment
VDA 1102 CTCL
Technology
Back
HK2 in Cancer
VDAC/HK2
VDAC/HK2 Modulators
Immuno-Metabolism
News & Events
Back
Press Releases
Events
Publications
Factsheet
Contact
Home
About
Back
About Us
Management Team
Board of Directors
Clinical Advisors
Factsheet
Pipeline
Back
Pipeline
VDA-1102 Ointment
VDA-1102 IV
VDA-1275
Therapeutic Areas
Back
Oncology
Back
Solid Tumors
Cutaneous T-Cell Lymphoma (CTCL)
Dermatology
Back
Skin Cancer
Cutaneous Squamous Cell Carcinoma (cSCC)
Actinic Keratosis
Clinical Trials
Back
VDA-1102 Ointment
VDA 1102 CTCL
Technology
Back
HK2 in Cancer
VDAC/HK2
VDAC/HK2 Modulators
Immuno-Metabolism
News & Events
Back
Press Releases
Events
Publications
Factsheet
Contact
News & Events
News & Events
Press Releases
Events
Publications
Factsheet
Factsheet
Vidac Pharma - Factsheet Dec 2020
Publications
Press Releases
LiveSites
|
Login
© 2016 - 2022 Vidac
To Top